Efficacy of once- and twice-daily administration of budesonide via Turbuhaler® as initial therapy in patients with mild persistent asthma
- 1 April 1999
- journal article
- clinical trial
- Published by Elsevier in Respiratory Medicine
- Vol. 93 (4) , 230-235
- https://doi.org/10.1016/s0954-6111(99)90018-5
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Efficacy and Cost Benefit of Inhaled Corticosteroids in Patients Considered to Have Mild Asthma in Primary Care PracticeCanadian Respiratory Journal, 1996
- Effects of Reducing or Discontinuing Inhaled Budesonide in Patients with Mild AsthmaNew England Journal of Medicine, 1994
- Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic childrenRespiratory Medicine, 1994
- Pulmicort® turbohaler® once daily as initial prophylactic therapy for asthmaRespiratory Medicine, 1994
- Lung volumes and forced ventilatory flowsEuropean Respiratory Journal, 1993
- Airway Mucosal Inflammation Even in Patients with Newly Diagnosed AsthmaAmerican Review of Respiratory Disease, 1993
- Comparison of a β2-Agonist, Terbutaline, with an Inhaled Corticosteroid, Budesonide, in Newly Detected AsthmaNew England Journal of Medicine, 1991
- Effect of Long-term Treatment with an Inhaled Corticosteroid (Budesonide) on Airway Hyperresponsiveness and Clinical Asthma in Nonsteroid-dependent AsthmaticsAmerican Review of Respiratory Disease, 1990
- Statement on Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease (COPD) and AsthmaAmerican Review of Respiratory Disease, 1987
- Influence of dosing frequency and schedule on the response of chronic asthmatics to the aerosol steroid, budesonideJournal of Allergy and Clinical Immunology, 1982